Jiangsu Ruitai New Energy Materials Co (301238) Fair Value & Analysis
Basic Materials · CN · Market cap 18.5B CNY
Analysis
Jiangsu Ruitai New Energy Materials Co (301238) currently trades at ¥26.30, while our model-based Fair Value estimate is ¥5.15 — implying the stock looks roughly 80.4% overvalued today. We read business quality at 94/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Jiangsu Ruitai New Energy Materials Co., Ltd. researches and develops, produces, and sells lithium-ion battery materials and new chemical materials in China and internationally. The company offers main electronic chemicals, including lithium-ion battery electrolytes, lithium-ion battery electrolyte additives, supercapacitor electrolytes, and optical materials; and lithium-ion battery electrolyte products, such as power battery, energy storage battery, and consumer battery electrolytes. It also provides lithium-ion battery electrolyte additives comprising lithium difluorophosphate, lithium bis(trifluoromethanesulfonyl)imide, lithium difluorooxalate borate, and lithium trifluoromethanesulfonate; electrolyte for supercapacitors; optical materials; and silane coupling agents. The company also exports its products. The company was founded in 2017 and is headquartered in Zhangjiagang, China. Jiangsu Ruitai New Energy Materials Co., Ltd. operates as a subsidiary of Jiangsu Guotai Internati…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.